The US Vision Care Market: Rising Demand for Eye Care Products Drives Growth, Forecast to Reach $33.4 Billion by 2028 Dublin, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The "US Vision Care Market: Analysis, Trends and Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The report offers a...

NR2E3 Mutation-Associated Retinal Degeneration Market Insights, Epidemiology and Forecasts, 2032 - Focus on United States, Germany, Spain, Italy, France, United Kingdom and Japan Dublin, June 08, 2023 (GLOBE NEWSWIRE) -- The "NR2E3 Mutation - Associated Retinal Degeneration - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ...

Leber Congenital Amaurosis Market Is Estimated to Grow at CAGR Of 4.8%, 2022-2029 | Latest Industry Coverage by Douglas Insights Douglas, Jan. 20, 2023 (GLOBE NEWSWIRE) -- The Leber Congenital Amaurosis Market Report by Douglas Insights aims to inform about the details of growing developments, market share, and any localized...

Connectyx Announces Grant of Exclusive Worldwide License from National Institutes of Health for Repurposing Metformin to Treat Degenerative Eye Disease Boca Raton, FL, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel...

Foundation Fighting Blindness Launches Natural History Study for People with Retinitis Pigmentosa Caused by EYS Gene Mutations Columbia, MD, Nov. 27, 2019 (GLOBE NEWSWIRE) -- The Foundation Fighting Blindness has launched a natural history study (NCT04127006) for people with retinitis pigmentosa (RP) caused by mutations in...